Healthpeak Properties, Inc. (DOC) Stock Forecast
DOC analyst forecast
as of October 18, 2026- Analyst consensus
- Buy 3.59 / 5 from 22 analysts
- Price target
- $22.61 average of analyst targets
- Upside to target
- +19.1% from the latest close
- Next earnings
- November 2, 2026 EPS estimate $0.43
- 52-week range
- $15.78 – $22.82
DOC analyst ratings
22 analystsNumber of analysts at each rating.
DOC price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
DOC earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.03 | $0.01 | $0.04 | −$0.18 | +113.7% | 2 |
| Current fiscal year (2026) | $0.09 | $0.09 | $0.09 | $0.04 | +130.8% | 1 |
| Next fiscal year (2027) | $0.14 | $0.12 | $0.16 | $0.09 | +55.6% | 2 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
DOC revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $743.5M | $689.0M | $768.5M | +7.7% | 7 |
| Current fiscal year (2026) | $2.94B | $2.53B | $3.06B | +6.6% | 10 |
| Next fiscal year (2027) | $3.17B | $2.85B | $3.45B | +7.8% | 9 |
DOC EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
DOC revenue: reported and forecast
DOC EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.00 | $0.00 | $0.00 | $0.00 | $0.03 | — | 0 up · 0 down |
| Current fiscal year (2026) | $0.15 | $0.00 | $0.00 | $0.00 | $0.09 | −40.0% | 0 up · 1 down |
| Next fiscal year (2027) | $0.15 | −$0.15 | −$0.15 | $0.14 | $0.14 | −6.7% | 0 up · 1 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
DOC earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; DOC beat in 10 of 12.
What analysts expect from DOC
22 analysts cover Healthpeak; their consensus rating is buy (3.59 on a 1–5 scale, where 5 is a strong buy). The average price target is $22.61, 19.1% above the latest close of $18.98. Analysts expect earnings of $0.09 per share for 2026, +130.8% from a year earlier. For 2027 the average estimate is $0.14 per share on revenue of $3.2 billion. Healthpeak beat the EPS estimate in 10 of the last 12 quarters.
Related: DOC income statement, DOC key metrics, DOC chart. See the DOC stock overview for the latest quote and news.
DOC forecast FAQ
What is Healthpeak's price target?
The average analyst price target for Healthpeak is $22.61, 19.1% above the latest close of $18.98.
Is Healthpeak a buy, hold or sell?
Of 22 analysts covering Healthpeak, 5 rate it a strong buy, 3 a buy, 14 a hold, 0 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Healthpeak's EPS forecast?
Analysts forecast $0.09 per share for 2026 (range $0.09 to $0.09); for 2027 the estimate is $0.14.
What is Healthpeak's revenue forecast?
The average revenue estimate for 2026 is $2.9 billion, growth of 6.6%; for 2027 it is $3.2 billion.
When does Healthpeak report earnings?
Healthpeak is expected to report results for the quarter ending September 30, 2026 on November 2, 2026 after the market closes; the EPS estimate is $0.43.
Does Healthpeak usually beat earnings estimates?
Healthpeak reported EPS at or above the analyst estimate in 10 of the last 12 quarters.